LIVE
Beyond the Scale: The Economic Power of GLP-1 Therapies
TechPolicy
1:25:03
The Bayh-Dole Act’s Role in Stimulating University-Led Regional Economic Growth
1:15:47
Making Medicines in America: How Congress Can Help AI, Biopharma & Manufacturing Industries
1:18:12
Innovate4Health: How IP and Innovation Are Solving Global Health Challenges
1:31:33
Preserving U.S. Leadership in Biopharmaceutical Innovation
1:17:13
Lessons From the Rise and Fall of Japan’s Life-Sciences Innovation Ecosystem
1:07:53
Preserving a Virtuous Cycle: The Economics of Biopharmaceutical Innovation
1:29:58
How Using March-in Rights Would Threaten America’s Research Universities
1:05:50
The Role of Intellectual Property Rights in Ending the COVID-19 Pandemic
1:32:13
How Intellectual Property Has Played a Pivotal Role in the Global COVID-19 Response
1:32:10
Seizing the Transformative Opportunity of Multi-Cancer Early Detection
1:29:13
March-In Rights for Federally-Funded Inventions: A Primer
1:03:51
Lessons Learned from Global Life Sciences Ecosystems in the COVID-19 Pandemic
1:02:07
The Critical Role of Biopharmaceutical Startups in Driving Life Sciences Innovation
1:14:49
How the Bayh-Dole Act Will Speed Development of Coronavirus Cures
1:32:05
Preserving Bayh-Dole—the “Inspired” Law That Underpins U.S. Leadership in Life-Sciences Innovation
1:27:14
How to Ensure That America’s Life-Sciences Sector Remains Globally Competitive
1:25:58
1:16:59
Speeding Cures for Patients: How Congress Can Update PDUFA to Spur Biopharmaceutical Innovation
1:10:57
A Trillion-Dollar Opportunity: How Brain Research Can Drive Health and Prosperity
